Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR.

Paul E HannaQiyu WangIan StrohbehnDaiana MorenoDestiny HardenTianqi OuyangNurit Katz-AgranovHarish SeethapathyKerry L ReynoldsShruti GuptaDavid E LeafMeghan E Sise

Published in: medRxiv : the preprint server for health sciences (2023)

, medication-related adverse events occur more commonly in those with eGFR discrepancy. These findings underscore the importance of accurate assessment of kidney function and appropriate dosing of renally-cleared medications in patients with cancer.

Keyphrases

small cell lung cancer
epidermal growth factor receptor
tyrosine kinase
healthcare
adverse drug
high resolution
uric acid
drug induced